Skip to main content

From Rx Drug Abuse & Heroin Summit

As the U.S. population ages, Elisha Figueroa, LMSW, CPS, and Angie Jones, MSSW, of JBS International say prevention professionals will need to sharpen the focus of their messaging when working with older adults.
In lieu of an in-person event, the 2020 Rx Drug Abuse & Heroin Summit will be presented online as a virtual experience during the conference’s originally scheduled dates, April 14-16.
Jodi Maiolo, MPH, CPH, and Shanen Wright will discuss a campaign to reduce stigma in Appalachia that they worked on and how some of their takeaways can be used to create more effective messaging in other communities.
Lisa McLaughlin, LLMSW, MSI, co-founder and co-CEO of Workit Health, explains how the company’s digital-first, harm-reduction approach is expanding access to care for diverse populations in Michigan and California.
CODAC Health Recovery & Wellness Inc. has established a service site with 24-hour access to support for patients with opioid use disorder.
John Temple, author of “American Pain,” will share findings from his book on a Florida pain clinic that recklessly prescribed opioids, as well as how some operators have now shifted into running treatment centers and sober living facilities.
Journalist Beth Macy, who will speak on a panel at the Rx Drug Abuse & Heroin Summit in April, discusses her findings while reporting for her New York Times bestselling book ‘Dopesick.’
A speaker at this spring's Rx Drug Abuse & Heroin Summit discusses the latest national data on emerging drug threats, highlighting the need to focus on stimulant trends.

Changes to medical marijuana laws, use of PDMPs state-by-state, and access to naloxone were among the legal topics covered during a breakout session Thursday at the Rx Summit.

The final plenary session at the Rx Drug Abuse & Heroin Summit served as a reminder that any location where persons with opioid use disorders can be found can offer effective evidence-based care.
Back to Top